Veterinary Medicines

HATCHPAK IB H120 NEO EFFERVESCENT TABLET FOR OCULONASAL SUSPENSION FOR CHICKENS

Authorised
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
Download as PDF

Product identification

Medicine name:
Hatchpak IB H120 Neo - Bruistablet voor suspensie voor oculonasaal gebruik
Hatchpak IB H120 Neo - Comprimé effervescent pour suspension oculonasale
Hatchpak IB H120 Neo - Brausetablette für okulonasale suspension
HATCHPAK IB H120 NEO EFFERVESCENT TABLET FOR OCULONASAL SUSPENSION FOR CHICKENS
Active substance:
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
Target species:
  • Chicken (one day-old chick)
Route of administration:
  • Oculonasal use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
    3.70
    50% Embryo Infective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Effervescent tablet
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken (one day-old chick)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Box of 1 blister of 10 tablets of 1,000 doses
  • Box of 10 blisters of 10 tablets of 2,000 doses
  • Box of 10 blisters of 10 tablets of 1,000 doses
  • Box of 1 blister of 10 tablets of 2,000 doses

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V502880
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0171/002
Concerned member states:
  • Belgium
  • Cyprus
  • Denmark
  • Finland
  • Germany
  • Greece
  • Iceland
  • Ireland
  • Italy
  • Netherlands
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 15/02/2023
Download
French (PDF)
Published on: 15/02/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 15/02/2023
Download
French (PDF)
Published on: 15/02/2023
Download
German (PDF)
Published on: 15/02/2023
Download